Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven Grant

Showing results (201-210 of 386) with videos related to

Pageof 39
Sort By:
Cancer Research|March 23, 2005
Coadministration of histone deacetylase inhibitors and perifosine synergistically induces apoptosis in human leukemia cells through Akt and ERK1/2 inactivation and the generation of ceramide and reactive oxygen speciesMohamed Rahmani, Erin Reese, Yun Dai, et al.
Molecular Cancer Therapeutics|October 15, 2008
Role of histone deacetylase inhibitor-induced reactive oxygen species and DNA damage in LAQ-824/fludarabine antileukemic interactionsRoberto R Rosato, Jorge A Almenara, Sonia C Maggio, et al.
Autophagy|August 23, 2008
Regulation of autophagy by ceramide-CD95-PERK signalingMargaret A Park, Guo Zhang, James Norris, et al.
Molecular Pharmacology|February 24, 2012
Lapatinib and obatoclax kill tumor cells through blockade of ERBB1/3/4 and through inhibition of BCL-XL and MCL-1Nichola Cruickshanks, Hossein A Hamed, M Danielle Bareford, et al.
Molecular Cancer Therapeutics|August 5, 2010
Sorafenib activates CD95 and promotes autophagy and cell death via Src family kinases in gastrointestinal tumor cellsMargaret A Park, Roland Reinehr, Dieter Häussinger, et al.
Oncotarget|April 19, 2017
Synergistic interactions between PLK1 and HDAC inhibitors in non-Hodgkin's lymphoma cells occur in vitro and in vivo and proceed through multiple mechanismsTri Nguyen, Rebecca Parker, Elisa Hawkins, et al.
International Journal of Oncology|November 18, 2004
The histone deacetylase inhibitor sodium butyrate induces breast cancer cell apoptosis through diverse cytotoxic actions including glutathione depletion and oxidative stressMonette Louis, Roberto R Rosato, Laurent Brault, et al.
Hepatology (Baltimore, Md.)|March 27, 2002
Inhibition of the MAPK and PI3K pathways enhances UDCA-induced apoptosis in primary rodent hepatocytesLiang Qiao, Adly Yacoub, Elaine Studer, et al.
Annals of Surgery|March 30, 2002
André Toupet: surgeon technician par excellenceNamir Katkhouda, Michael R Khalil, Sharan Manhas, et al.
Cancer Research|May 3, 2003
Histone deacetylase inhibitors promote STI571-mediated apoptosis in STI571-sensitive and -resistant Bcr/Abl+ human myeloid leukemia cellsChunrong Yu, Mohamed Rahmani, Jorge Almenara, et al.
Pageof 39

Showing results (201-210 of 386) with videos related to

Sort By:
Pageof 39
Cancer Research|March 23, 2005
Coadministration of histone deacetylase inhibitors and perifosine synergistically induces apoptosis in human leukemia cells through Akt and ERK1/2 inactivation and the generation of ceramide and reactive oxygen speciesMohamed Rahmani, Erin Reese, Yun Dai, et al.
Molecular Cancer Therapeutics|October 15, 2008
Role of histone deacetylase inhibitor-induced reactive oxygen species and DNA damage in LAQ-824/fludarabine antileukemic interactionsRoberto R Rosato, Jorge A Almenara, Sonia C Maggio, et al.
Autophagy|August 23, 2008
Regulation of autophagy by ceramide-CD95-PERK signalingMargaret A Park, Guo Zhang, James Norris, et al.
Molecular Pharmacology|February 24, 2012
Lapatinib and obatoclax kill tumor cells through blockade of ERBB1/3/4 and through inhibition of BCL-XL and MCL-1Nichola Cruickshanks, Hossein A Hamed, M Danielle Bareford, et al.
Molecular Cancer Therapeutics|August 5, 2010
Sorafenib activates CD95 and promotes autophagy and cell death via Src family kinases in gastrointestinal tumor cellsMargaret A Park, Roland Reinehr, Dieter Häussinger, et al.
Oncotarget|April 19, 2017
Synergistic interactions between PLK1 and HDAC inhibitors in non-Hodgkin's lymphoma cells occur in vitro and in vivo and proceed through multiple mechanismsTri Nguyen, Rebecca Parker, Elisa Hawkins, et al.
International Journal of Oncology|November 18, 2004
The histone deacetylase inhibitor sodium butyrate induces breast cancer cell apoptosis through diverse cytotoxic actions including glutathione depletion and oxidative stressMonette Louis, Roberto R Rosato, Laurent Brault, et al.
Hepatology (Baltimore, Md.)|March 27, 2002
Inhibition of the MAPK and PI3K pathways enhances UDCA-induced apoptosis in primary rodent hepatocytesLiang Qiao, Adly Yacoub, Elaine Studer, et al.
Annals of Surgery|March 30, 2002
André Toupet: surgeon technician par excellenceNamir Katkhouda, Michael R Khalil, Sharan Manhas, et al.
Cancer Research|May 3, 2003
Histone deacetylase inhibitors promote STI571-mediated apoptosis in STI571-sensitive and -resistant Bcr/Abl+ human myeloid leukemia cellsChunrong Yu, Mohamed Rahmani, Jorge Almenara, et al.
Pageof 39